Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2‐dependent cell line and preparation of anti‐IL 6 monoclonal antibodies
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Murine hybridomas producing monoclonal antibodies (mAb) specific to human interleukin 6 (IL6/BSF‐2) were established. One of these hybridomas (MH60.BSF2) was found to be dependent on IL6 for its in vitro growth. None of the known biological factors tested, such as recombinant (r) human (Hu) Illα, rHuILlα, rHuIL2, rHuIL3, rHuIL4, rHu interferon (1FN)‐γ, HuIFN‐β, rHuG‐CSF, or recombinant murine (Mu) IL3, MuIL4, rMuIL5, could induce the in vitro growth of MH60.BSF2 cells. The half‐maximum tritiated thymidine uptake by MH60.BSF2 cells could be achieved by picogram amounts of rIL 6, making this hybridoma clone an indicator cell for specific and sensitive detection of the IL6 activity in test samples. The MH166.BSF2 clone was found to produce IgG l,χ type mAb (αBSF2‐166) capable of neutralizing IL6 activity. The other clone, MH60.BSF2, produced IgM,x type mAb (aBSF2‐60) unable to neutralize IL6 activity. Both mAb specifically reacted with IL6 as demonstrated by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis and Western blotting analysis. An enzyme‐linked immunosorbent assay (ELISA) utilizing αBSF2‐166 and rabbit anti‐IL 6 antibodies was established which could detect as low as 50 pg/ml of IL6. Since both the ELISA and MH60.BSF2 hybridoma could detect small amounts of IL6 in biological fluids, they constitute powerful tools in exploring the presence or the role of IL6 in various immunological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Self-citationSelected methods in cellular immunology
(1981) · Annales de l'Institut Pasteur / Immunologie · doi:10.1016/0769-2625(81)90037-4 · Cited by 1,959
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
Self-citationIkebuchi, K., Wong, G. G., Clark, S. C., Ihle, J. N., Hirai, Y., & Ogawa, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9035 · Cited by 802
Van Snick, J., Cayphas, S., Vink, A., Uyttenhove, C., Coulie, P. G., Rubira, M. R., & Simpson, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9679 · Cited by 680
Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K. H., & Kishimoto, T. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5490 · Cited by 677
Self-citationVan Damme, J., Opdenakker, G., Simpson, R. J., Rubira, M. R., Cayphas, S., Vink, A., Billiau, A., & Van Snick, J. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.3.914 · Cited by 669
Molecular Regulation of B Lymphocyte Response
Kishimoto, T., & Hirano, T. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.002413 · Cited by 567
Self-citation
Cited by
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Self-citationPathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease
Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., & Komori, T. (1989) · Blood · doi:10.1182/blood.v74.4.1360.1360 · Cited by 928
Self-citationExcessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Self-citationYoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara, T., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07281.x · Cited by 753
IgG1 plasmacytosis in interleukin 6 transgenic mice
Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., & Kishimoto, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7547 · Cited by 586
Self-citationInterleukin-6 in the Injured Patient: Marker of Injury or Mediator of Inflammation?
Biffl, W. L., Moore, E. E., Moore, F. A., & Peterson, V. M. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00009 · Cited by 502
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.
Miles, S. A., Rezai, A. R., Salazar-González, J. F., Vander Meyden, M., Stevens, R. H., Logan, D. M., Mitsuyasu, R. T., Taga, T., Hirano, T., & Kishimoto, T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4068 · Cited by 475
Self-citationLe, J., & Vilček, J. (1990) · Pathology Reviews • 1990 · doi:10.1007/978-1-4612-0485-5_7 · Cited by 474
Assessment of Cytokines by Immunofluorescence and the Paraformaldehyde‐Saponin Procedure
Sander, B., Andersson, J., & Andersson, U. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00578.x · Cited by 452
Interleukin-6 is a potent thrombopoietic factor in vivo in mice
Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., Kariyone, S., Hirano, T., Kishimoto, T., Takatsuki, F., & Akiyama, Y. (1989) · Blood · doi:10.1182/blood.v74.4.1241.1241 · Cited by 432
Self-citationTsujinaka, T., Fujita, J., Ebisui, C., Yano, M., Kominami, E., Suzuki, K., Tanaka, K., Katsume, A., Ohsugi, Y., Shiozaki, H., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118398 · Cited by 421
Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas
Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., & Kishimoto, T. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80805-1 · Cited by 411
Self-citationHuman interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.
Ishibashi, T., Kimura, H., Uchida, T., Kariyone, S., Friese, P., & Burstein, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5953 · Cited by 407
IL-6 increases endothelial permeability in vitro
Maruo, N. (1992) · Endocrinology · doi:10.1210/en.131.2.710 · Cited by 386
Hypoxic Stress Induces Cardiac Myocyte–Derived Interleukin-6
Yamauchi-Takihara, K., Ihara, Y., Ogata, A., Yoshizaki, K., Azuma, J., & Kishimoto, T. (1995) · Circulation · doi:10.1161/01.cir.91.5.1520 · Cited by 304
Self-citationHirohata, S., & Miyamoto, T. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330506 · Cited by 273
Sensitive ELISA for interleukin-6
Helle, M., Boeije, L., de Groot, E., de Vos, A., & Aarden, L. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90063-l · Cited by 248
Suematsu, S., Matsusaka, T., Matsuda, T., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., & Kishimoto, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.232 · Cited by 227
Self-citationAutoregulation of the Stat3 Gene through Cooperation with a cAMP-responsive Element-binding Protein
Ichiba, M., Nakajima, K., Yamanaka, Y., Kiuchi, N., & Hirano, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6132 · Cited by 175
Self-citationKatsume, A., Saito, H., Yamada, Y., Yorozu, K., Ueda, O., Akamatsu, K.-I., Nishimoto, N., Kishimoto, T., Yoshizaki, K., & Ohsugi, Y. (2002) · Cytokine · doi:10.1006/cyto.2002.2012 · Cited by 134
Self-citationAbe, K., Hirai, M., Mizuno, K., Higashi, N., Sekimoto, T., Miki, T., Hirano, T., & Nakajima, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204461 · Cited by 65
“In addition, we established three MH60 B cell hybridoma cell lines: one expressed G133; one expressed G133F2, with a Tyr to Phe mutation at the second tyrosine residue (in the YSTV motif); the third expressed G133F3, with a Tyr to Phe mutation at the third tyrosine residue (in the YRHQ motif) (see Figure 2a).”
MethodInfluentialSelf-citationHirano, T., & Kishimoto, T. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-49295-2_14 · Cited by 57
Self-citation
Metadata
- Authors
- Matsuda, T., And, T. H., & Kishimoto, T.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1988-06
- Volume
- 18
- Issue
- 6
- Pages
- 951-956
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2005592215
- Cited by
- 304
- References
- 20
- FWCI
- 16.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.